|
|
 |
|
Total Number of Holdings (excluding cash): 50
| Demant A/S |
DEMANT.DC |
K3008M105 |
1,896 |
$80,402.83 |
2.74% |
| Baxter International Inc. |
BAX |
071813109 |
3,441 |
$80,312.94 |
2.73% |
| LivaNova Plc |
LIVN |
G5509L101 |
940 |
$75,745.20 |
2.58% |
| West Pharmaceutical Services, Inc. |
WST |
955306105 |
229 |
$75,856.25 |
2.58% |
| WuXi AppTec Co., Ltd. (Class H) |
2359.HK |
Y971B1118 |
3,577 |
$71,725.93 |
2.44% |
| Revvity, Inc. |
RVTY |
714046109 |
657 |
$71,001.99 |
2.42% |
| Agilent Technologies, Inc. |
A |
00846U101 |
513 |
$70,737.57 |
2.41% |
| Waters Corporation |
WAT |
941848103 |
184 |
$68,300.80 |
2.32% |
| Sonova Holding AG (Registered) |
SOON.SW |
H8024W106 |
255 |
$67,739.64 |
2.31% |
| DexCom, Inc. |
DXCM |
252131107 |
921 |
$67,573.77 |
2.30% |
| Sysmex Corporation |
6869.JP |
J7864H102 |
6,834 |
$66,893.44 |
2.28% |
| Bio-Rad Laboratories, Inc. (Class A) |
BIO |
090572207 |
211 |
$66,762.51 |
2.27% |
| Olympus Corporation |
7733.JP |
J61240107 |
6,040 |
$66,659.89 |
2.27% |
| Thermo Fisher Scientific Inc. |
TMO |
883556102 |
118 |
$66,024.54 |
2.25% |
| Merit Medical Systems, Inc. |
MMSI |
589889104 |
864 |
$65,750.40 |
2.24% |
| Straumann Holding AG (Registered) |
STMN.SW |
H8300N127 |
552 |
$65,194.09 |
2.22% |
| Teleflex Incorporated |
TFX |
879369106 |
498 |
$65,262.90 |
2.22% |
| Edwards Lifesciences Corporation |
EW |
28176E108 |
757 |
$62,861.28 |
2.14% |
| Carl Zeiss Meditec AG (Bearer) |
AFX.GY |
D14895102 |
1,939 |
$61,637.95 |
2.10% |
| Abbott Laboratories |
ABT |
002824100 |
588 |
$61,440.12 |
2.09% |
| Terumo Corporation |
4543.JP |
J83173104 |
4,460 |
$61,289.84 |
2.09% |
| Becton, Dickinson and Company |
BDX |
075887109 |
382 |
$60,707.44 |
2.07% |
| Danaher Corporation |
DHR |
235851102 |
310 |
$60,915.00 |
2.07% |
| Fisher & Paykel Healthcare Corporation Limited |
FPH.NZ |
Q38992105 |
2,616 |
$60,164.34 |
2.05% |
| Mettler-Toledo International Inc. |
MTD |
592688105 |
45 |
$60,133.05 |
2.05% |
| Stryker Corporation |
SYK |
863667101 |
174 |
$58,592.76 |
1.99% |
| The Cooper Companies, Inc. |
COO |
216648501 |
828 |
$58,200.12 |
1.98% |
| Zimmer Biomet Holdings, Inc. |
ZBH |
98956P102 |
633 |
$58,280.31 |
1.98% |
| Steris Plc |
STE |
G8473T100 |
265 |
$57,876.00 |
1.97% |
| Align Technology, Inc. |
ALGN |
016255101 |
340 |
$57,137.00 |
1.94% |
| Medtronic Plc |
MDT |
G5960L103 |
676 |
$56,932.72 |
1.94% |
| Penumbra, Inc. |
PEN |
70975L107 |
178 |
$56,869.22 |
1.94% |
| Coloplast A/S (Class B) |
COLOB.DC |
K16018192 |
877 |
$55,903.28 |
1.90% |
| Sartorius Stedim Biotech |
DIM.FP |
F8005V210 |
295 |
$54,363.29 |
1.85% |
| Smith & Nephew Plc |
SN/.LN |
G82343164 |
3,516 |
$54,228.89 |
1.85% |
| Siemens Healthineers AG |
SHL.GY |
D6T479107 |
1,332 |
$53,720.30 |
1.83% |
| Koninklijke Philips N.V. |
PHIA.NA |
N7637U112 |
2,073 |
$53,196.14 |
1.81% |
| ResMed Inc. |
RMD |
761152107 |
258 |
$52,394.64 |
1.78% |
| Alcon Inc. |
ALC.SW |
H01301128 |
756 |
$51,229.10 |
1.74% |
| Globus Medical, Inc. (Class A) |
GMED |
379577208 |
652 |
$51,019.00 |
1.74% |
| LeMaitre Vascular, Inc. |
LMAT |
525558201 |
514 |
$50,850.02 |
1.73% |
| GE HealthCare Technologies Inc. |
GEHC |
36266G107 |
807 |
$49,323.84 |
1.68% |
| Insulet Corporation |
PODD |
45784P101 |
300 |
$49,500.00 |
1.68% |
| Intuitive Surgical, Inc. |
ISRG |
46120E602 |
130 |
$46,387.90 |
1.58% |
| Shanghai Microport Medbot (Group) Co., Ltd. (Class H) |
2252.HK |
Y768JD106 |
16,500 |
$45,222.60 |
1.54% |
| BioMerieux |
BIM.FP |
F1149Y232 |
558 |
$44,740.57 |
1.52% |
| Hoya Corporation |
7741.JP |
J22848105 |
294 |
$43,840.84 |
1.49% |
| Boston Scientific Corporation |
BSX |
101137107 |
955 |
$43,462.05 |
1.48% |
| Cochlear Limited |
COH.AU |
Q25953102 |
484 |
$38,603.89 |
1.31% |
| US Dollar |
$USD |
|
14,909 |
$14,908.88 |
0.51% |
| Euro |
$EUR |
|
0 |
$0.06 |
0.00% |
| Pound Sterling |
$GBP |
|
0 |
$0.15 |
0.00% |
| TPG Inc. (CVR) |
2602335D |
436CVR021 |
612 |
$0.00 |
0.00% |
Holdings are subject to change.
The holdings information set forth above for the date indicated reflects creation and redemption transactions from the prior business day and may differ from the holdings information currently available from the Fund's custodian and accounting agent. With respect to the market value of the Fund's holdings set forth above, the pricing sources are generally third party vendors. The Fund ultimately relies on pricing information provided by the Fund's accounting agent.
|
|
The information presented is not intended to constitute an investment recommendation for, or advice to, any specific person. By providing this information, First Trust is not undertaking to give advice in any fiduciary capacity within the meaning of ERISA, the Internal Revenue Code or any other regulatory framework. Financial professionals are responsible for evaluating investment risks independently and for exercising independent judgment in determining whether investments are appropriate for their clients.
|